RA

Rizwan Ali

Active Director Director DIN 07921774
DIN 07921774 First appointment Sep 2017 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Rizwan Ali

Data last updated:

Rizwan Ali is a Director at Zeinac Pharmaceuticals Private Limited (since 2017). The company operates in Business Services. Zeinac Pharmaceuticals Private Limited reported revenue of ₹12.1 Lakh (FY 2024).

DIN 07921774
Primary Designation Director
Industry Business Services
First Appointment 25 Sep 2017
Oldest Company Age 9 yrs
Largest company Zeinac Pharmaceuticals Private Limited · ₹12.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20172017₹12.1 Lakh (FY 2024)Active

Board colleagues of Rizwan Ali

NameDINCompanyDesignation
Shakir Ali07921777Zeinac Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zeinac Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rizwan Ali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rizwan Ali

Rizwan Ali currently holds 1 directorship: Zeinac Pharmaceuticals Private Limited (Director, since 25 Sep 2017, revenue ₹12.1 Lakh (FY 2024)).

Rizwan Ali was first appointed on 25 Sep 2017 as Director at Zeinac Pharmaceuticals Private Limited.

The current boards of Rizwan Ali's companies include Shakir Ali (Zeinac Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available